Two California universities and MIT team up to create a polymer-protected nanoworm that may one day make it possible to deliver cancer drugs directly to tumors.

Breast cancer survivors in Connecticut can get professional help dealing with troublesome treatment side effects thanks to a generous grant and Easter Seals.

At 33, Lori Hamilton is on the race circuit helping manage a NASCAR team and raising awareness about head and neck cancer, the disease that killed her husband.

Mathematical theories and hefty grants are helping a British engineer create better models of cancer and hospital ventilators. Feedback control is the key.

90,000 patients wait for organ transplants, but some organs are lost because they aren’t harvested in time. NYC officials propose a controversial solution.

Physicians from Uganda and Connecticut discuss abstinence, condoms, cancer, HIV, and snow (plus a few other interesting topics) on Yale Cancer Center Answers.

Canadian officials begin a new smoking ban in federal prisons. Some think it’s the perfect chance to quit — others worry withdrawal will lead to violence.

Experts face the grim task of deciding who will get treatment during a pandemic or other health disaster — many with chronic illnesses will be left out.

Scientists from the Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY) have discovered a method which makes it possible to deliver powerful RNA interference (RNAi) therapies directly to the precise location where cancer or viral infections are developing. RNAi therapies are designed to turn on and off disease-causing genes. Early RNAi studies [...]

A study led by the Fred Hutchinson Cancer Research Center suggests that tumors with intact P53 genes may respond better to prostate cancer treatments designed to target insulin-like growth factor 1 receptors (IGF-1R). Fred Hutchinson’s findings could have an important impact on more than a dozen clinical trials currently being conducted to test IGF-1R inhibitors. [...]